AnaCardio Revenue and Competitors
Employee Data
- AnaCardio has 23 Employees.
- AnaCardio grew their employee count by 44% last year.
AnaCardio's People
Name | Title | Email/Phone |
---|
AnaCardio Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | N/A | 16 | 7% | N/A | N/A |
#2 | N/A | 27 | 13% | N/A | N/A |
#3 | N/A | 128 | 20% | N/A | N/A |
#4 | N/A | 23 | 44% | N/A | N/A |
What Is AnaCardio?
AnaCardio AB is a privately held Swedish, clinical stage biopharmaceutical company developing novel drugs to treat heart failure. AnaCardio was founded based on ground-breaking research from Karolinska Institutet showing improved contractility of the heart muscle through a unique and differentiated mechanism. Its lead program AC01 is planned to enter phase 2 clinical development in heart failure patients in 2022. You can find more information about AnaCardio at www.anacardio.com.
keywords:N/AN/A
Total Funding
23
Number of Employees
N/A
Revenue (est)
44%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $2.4M | 23 | -66% | N/A |
#2 | $2M | 24 | 0% | N/A |
#3 | $3M | 27 | 42% | N/A |
#4 | $2.7M | 27 | -4% | N/A |
#5 | $5.4M | 27 | 0% | N/A |